Pharmafile Logo
Pharmafocus logo
Advanced Search
GSK image

Corruption probe hits GSK

October 24, 2013
Sales and Marketing China, GSK, Q3, corruption

The fallout from corruption investigations in China has hit GlaxoSmithKline, which announced third quarter sales in the country were down …

News
open access image

Open access splits researchers

October 24, 2013
Medical Communications, Research and Development, Sales and Marketing BMJ, open access, publishing, research

Small medical research charities are worried that the extra costs of open access publishing will have a significant impact on …

News
dav

Horizon Discovery chairman steps down from Board

October 24, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing evans, horizon

Research tools firm Horizon Discovery has confirmed that David Evans has stepped down as chairman of its Board. Dr Ian …

Appointment
Simon Stevens

NHS England poaches new CEO from private sector

October 24, 2013
Medical Communications Mid Staffs, NHS England, Simon Stevens, Sir David Nicholson

News
Novartis image

Novartis sees profit slip

October 23, 2013
Sales and Marketing Afinitor, Diovan, Novartis, Q3, gilenya

Novartis saw generic competition erode profit in the third quarter of the year, although sales across the group actually rose …

News
Monster manor image

Sanofi launches ‘Monster Manor’ diabetes app

October 23, 2013
Medical Communications Gamification, Sanofi, diabetes, monster manor

Sanofi has launched a new healthcare app called Monster Manor to help children with type 1 diabetes better manage their …

News

Indian pharma exports ‘set for 20% growth’ to 2018

October 23, 2013
Manufacturing and Production API, CPhI, GMP, India, growth

Representatives of India’s pharma sector pledged to meet the government’s target of raising exports to $25 billion by 2016, as …

News
Reckitt Benckiser image

Reckitt Benckiser may shed pharma unit

October 23, 2013
Sales and Marketing Reckitt Benckiser Pharmaceuticals, rbp, suboxone

Reckitt Benckiser Pharmaceuticals is considering selling its pharma unit within the next year after the recent loss of its biggest …

News
capture

HGS founders join IMS Health team

October 23, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HGS, IMS Health, mcfarlane

Healthcare services firm IMS Health has appointed HGS Europe founders Graeme McFarlane and Angela McFarlane (pictured) to its UK team. 

Appointment
Jetrea image

NICE ‘yes’ for Jetrea

October 23, 2013
Sales and Marketing Jetrea, NHS, NICE, eye

Jetrea has completed its seemingly inexorable journey to NHS use in England and Wales for a rare eye condition following …

News
AstraZeneca imge

AZ begins late-stage trial of new cancer drug

October 22, 2013
Research and Development, Sales and Marketing AstraZeneca, Cancer, NSCLC, selumetinib

AstraZeneca has begun a Phase III study for its investigational lung cancer pill selumetinib in patients with a genetic sub-type …

News
gsk image

US regulator ponders Arzerra

October 22, 2013
Sales and Marketing Arzerra, CLL, FDA, GSK

GlaxoSmithKline and Genmab have submitted their blood cancer drug Arzerra to the FDA as a first-line treatment for chronic lymphocytic …

News
sian_dodwell_plbr

Former GSK director joins Publicis Life Brands Resolute

October 22, 2013
Manufacturing and Production, Research and Development, Sales and Marketing GSK, PLBR, publicis

Former director of branding and communications at GlaxoSmithKline Consumer Health Sian Dodwell, has joined Publicis Life Brands Resolute (PLBR) from …

Appointment
Actelion image

Opsumit wins US approval

October 22, 2013
Sales and Marketing actelion fda, opsumit

The FDA has approved Actelion’s oral endothelin receptor antagonist Opsumit as a treatment for pulmonary arterial hypertension (PAH), a potentially …

News

Effectively outsourcing medical and laboratory equipment procurement

October 21, 2013

With Investigator Sites located across the World it is increasingly important to ensure that they all have the right equipment …

Feature
Thought Leadership
iclusig image

Ariad ditches CML trial

October 21, 2013
Research and Development, Sales and Marketing Ariad, CML, iclusig

Ariad Pharmaceuticals has ditched its late-stage trial of Iclusig in patients with newly-diagnosed chronic myeloid leukemia (CML) after blood clots …

News
Eisai image

Eisai: reform NICE or we’ll pull out of the UK

October 21, 2013
Research and Development, Sales and Marketing Eisai, Hatfield, Hunt, NICE

Eisai has criticised NICE for being too narrow minded on assessing new drugs, and has warned it may pull its …

News

No closer to Alzheimer’s cure despite rise in research

October 21, 2013
Research and Development, Sales and Marketing Alzheimer's, depression, markram

A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …

News
Herceptin image

The new paradigm in oncology drug marketing

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology

Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …

Feature
jacek_glinka_mylan

Mylan hires president of European business

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, glinka

Mylan has announced that from December Jacek Glinka will be the president of its European business. Glinka served as chief …

Appointment
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026